Literature DB >> 18276990

Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage.

Dorota Halicka1, Masamichi Ita, Toshiki Tanaka, Akira Kurose, Zbigniew Darzynkiewicz.   

Abstract

Cepharanthine (CEP), a biscoclaurine (bisbenzylisoquinoline) alkaloid isolated from Stephania cepharantha Hayata, is widely used in Japan to treat variety of diseases. Among a plethora of its biological activities CEP was reported to be able to scavenge radicals and prevent lipid peroxidation. We have recently described the phenomenon of constitutive ATM activation (CAA) and histone H2AX phosphorylation (CHP), the events that report DNA damage induced by endogenously generated radicals, the product of oxidative metabolism in otherwise healthy, untreated cells. The aim of the present study was to explore whether CEP can attenuate the level of CAA and CHP, which would indicate on its ability to protect DNA against endogenous oxidants. The data show that indeed the levels of CAA and CHP in human lymphoblastoid TK6 cells were distinctly lowered upon treatment with CEP. Thus, exposure of cells to 8.3 microM CEP for 4 h led to a reduction of the mean level of CAA and CHP by up to 60% and 50%, respectively. At 1.7 microM CEP the reduction of CAA and CHP after 4 h was 35% and 25%, respectively. Cells exposure to CEP led to a decrease in the level of ondogenous oxidants as measured by the ability to oxidate the fluorescent probe 5-(and-6)-carboxy-2',7'-dichloro-dihydro-fluorescein diacetate. No evidence of apoptosis was seen during the first 8 h of treatment with CEP but initiation of apoptosis (caspase-3 activation) was detected in relatively few (< 10%) cells after exposure to 8.3 microM CEP for 24 h. The data strongly suggest that the scavenging properties of CEP provide a protection of DNA from the radicals generated endogenously during oxidative metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18276990      PMCID: PMC2577765     

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  52 in total

1.  Protection of T cells from radiation-induced apoptosis by Cepharanthin.

Authors:  H Oyaizu; Y Adachi; R Yasumizu; M Ono; K Ikebukuro; S Fukuhara; S Ikehara
Journal:  Int Immunopharmacol       Date:  2001-11       Impact factor: 4.932

2.  Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.

Authors:  Kazumasa Morita; Motonobu Nakamura; Miyako Nagamachi; Tatsuo Kishi; Yoshiki Miyachi
Journal:  J Dermatol       Date:  2002-10       Impact factor: 4.005

3.  The TP53 dependence of radiation-induced chromosome instability in human lymphoblastoid cells.

Authors:  Jeffrey L Schwartz; Robert Jordan; Helen H Evans; Marek Lenarczyk; Howard Liber
Journal:  Radiat Res       Date:  2003-06       Impact factor: 2.841

Review 4.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

5.  Re-evaluation of antitumor activity of Cepharanthin.

Authors:  Hiroshi Terasaka; Mamoru Machino; Masatoshi Saito; Seiichiro Fujisawa; Kazue Satoh; Yi Jiang; Hiroshi Sakagami
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

6.  Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody.

Authors:  Olga A Sedelnikova; Emmy P Rogakou; Igor G Panyutin; William M Bonner
Journal:  Radiat Res       Date:  2002-10       Impact factor: 2.841

7.  Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation.

Authors:  P Pozarowski; X Huang; D H Halicka; B Lee; G Johnson; Z Darzynkiewicz
Journal:  Cytometry A       Date:  2003-09       Impact factor: 4.355

8.  Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer.

Authors:  Michael M Vilenchik; Alfred G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

9.  Direct radical scavenging by the bisbenzylisoquinoline alkaloid cepharanthine.

Authors:  Kentaro Kogure; Koichiro Tsuchiya; Kazutoyo Abe; Michinori Akasu; Toshiaki Tamaki; Kenji Fukuzawa; Hiroshi Terada
Journal:  Biochim Biophys Acta       Date:  2003-06-20

10.  Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.

Authors:  Koji Harada; Shin Yamamoto; Shin-Ichi Kawaguchi; Hideo Yoshida; Mitsunobu Sato
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

View more
  7 in total

Review 1.  In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.

Authors:  Zbigniew Darzynkiewicz; Hong Zhao; H Dorota Halicka; Jiangwei Li; Yong-Syu Lee; Tze-Chen Hsieh; Joseph M Wu
Journal:  Cytometry A       Date:  2014-02-22       Impact factor: 4.355

2.  Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.

Authors:  Masamichi Ita; H Dorota Halicka; Toshiki Tanaka; Akira Kurose; Barbara Ardelt; Kuslima Shogen; Zbigniew Darzynkiewicz
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

3.  Fluoroquinolones lower constitutive H2AX and ATM phosphorylation in TK6 lymphoblastoid cells via modulation of the intracellular redox status.

Authors:  H Dorota Halicka; Daniel J Smart; Frank Traganos; Gary M Williams; Zbigniew Darzynkiewicz
Journal:  Pharmacol Rep       Date:  2009 Jul-Aug       Impact factor: 3.024

4.  Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling.

Authors:  H Dorota Halicka; Hong Zhao; Jiangwei Li; Frank Traganos; Sufang Zhang; Marietta Lee; Zbigniew Darzynkiewicz
Journal:  Aging (Albany NY)       Date:  2011-10       Impact factor: 5.682

5.  FK-3000 isolated from Stephania delavayi Diels. inhibits MDA-MB-231 cell proliferation by decreasing NF-κB phosphorylation and COX-2 expression.

Authors:  Hong De Xu; Soon-Chang Cho; Mi-Ae Bang; Chun-Sik Bae; Yeonshik Choi; Yong-Chun Li; Seung-Kil Lim; Jaegal Shim; Dae-Hun Park
Journal:  Int J Oncol       Date:  2015-03-27       Impact factor: 5.650

Review 6.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

7.  Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.

Authors:  H Dorota Halicka; Hong Zhao; Jiangwei Li; Yong-Syu Lee; Tze-Chen Hsieh; Joseph M Wu; Zbigniew Darzynkiewicz
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.